Last reviewed · How we verify
NCT03847402
The Early Integrated Intervention for Child Brain-developmental Disorders in China
NA trial testing The early integrated intervention for GDD in Brain Developmental Diseases in 900 participants. Completed in 30 July 2021.
30 June 2021
Quick facts
| Lead sponsor | Children's Hospital of Fudan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 900 |
| Start date | 15 June 2018 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 July 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- The early integrated intervention for GDD
- The early integrated intervention for ASD
- The early integrated intervention for ADHD
- community intervention for ASD
- Community intervention for GDD
- community intervention for ADHD
Conditions studied
- Brain Developmental Diseases — all drugs for Brain Developmental Diseases →
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
- Global Developmental Delay — all drugs for Global Developmental Delay →
- Attention Deficit-Hyperactivity Disorder — all drugs for Attention Deficit-Hyperactivity Disorder →
Sponsor
Children's Hospital of Fudan University
Who can join
Adults 3 Months to 3, any sex, with Brain Developmental Diseases or Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is focused on developing the early integrated intervention for child brain-developmental disorders, including globe developmental delay (GDD), autism spectrum disorder (ASD), and attention deficit-hyperactivity disorder (ADHD), in China.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Motor impairments in Chinese toddlers with autism spectrum disorder and its relationship with social communicative skills.
Zhou B, Xu Q, Li H, Zhang Y, et al · · 2022 · cited 7× · PMID 36311507 · DOI 10.3389/fpsyt.2022.938047
Verify or expand the search:
- PubMed search for NCT03847402
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Children's Hospital of Fudan University trials
Trials by the same sponsor.
- NCT04955821 — Early Identification of Pathogens in Children With Respiratory Tract Infection by Mechanical Ventilation Using mNGS · not yet recruiting
- NCT05862688 — A Cohort Study on Anti-microbial Stewardship in PICU · not yet recruiting
- NCT05595239 — Blood Purification in Septic Children · NA · not yet recruiting
- NCT07325903 — Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty · EARLY_PHASE1 · not yet recruiting
- NCT07141615 — Clinical Observation of Qingwei Huazhuo Decoction (Product: Jinsaiyu) in Improving Children With Precocious Puberty of P · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03847402 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Hospital of Fudan University
- Last refreshed: 11 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03847402.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing